PMEF
TRML

Point72 Middle East FZE’s Tourmaline Bio TRML Stock Holding History

Point72 Middle East FZE’s Portfolio TRML Stock Details TRML Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-1,040
Closed -$27.2K – 1209
2023
Q4 		$27.2K Buy
+1,040
New +$20.8K ﹤0.01% 1343

Other funds holding TRML

ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
BOCH
Blue Owl Capital Holdings New York $372M AUM 78.25% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
QF
QVT Financial New York $1.37B AUM 148.1% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
QUSVM
Qiming U.S. Ventures Management Bellevue, Washington $55.6M AUM 98.09% 1-Year Est. Return

Point72 Middle East FZE's TRML Position: Q1 2024 in Review

Point72 Middle East FZE sold out of Tourmaline Bio (TRML) in Q1 2024, closing a stake of 1,040 shares — an estimated $27.2K sold.

Point72 Middle East FZE first reported a position in TRML in Q4 2023 and held it in 1 quarter. The position peaked at $27.2K in Q4 2023. 96 funds tracked by Wall St. Rank hold TRML as of Q1 2024.

  • Point72 Middle East FZE reported no remaining Tourmaline Bio position as of Q1 2024 after selling out during the quarter.
  • Point72 Middle East FZE sold 1,040 Tourmaline Bio shares in Q1 2024, an estimated $27.2K.
  • Point72 Middle East FZE first reported a position in Tourmaline Bio in Q4 2023 and held it in 1 quarter.
  • Point72 Middle East FZE's Tourmaline Bio position peaked at $27.2K in Q4 2023.
  • 96 funds tracked by Wall St. Rank held Tourmaline Bio as of Q1 2024.

Based on Point72 Middle East FZE's 13F filing for Q1 2024.